GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹176 Cr | ₹255 Cr | ₹283 Cr | ₹366 Cr | ₹486 Cr |
What is the latest Total Non-Current Liabilities ratio of GRANULES INDIA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹176 Cr |
Mar2023 | ₹255 Cr |
Mar2022 | ₹283 Cr |
Mar2021 | ₹366 Cr |
Mar2020 | ₹486 Cr |
How is Total Non-Current Liabilities of GRANULES INDIA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹176 Cr | -30.89 | |
Mar2023 | ₹255 Cr | -9.94 | |
Mar2022 | ₹283 Cr | -22.79 | |
Mar2021 | ₹366 Cr | -24.63 | |
Mar2020 | ₹486 Cr | - |
Compare Total Non-Current Liabilities of peers of GRANULES INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GRANULES INDIA | ₹12,788.2 Cr | 2.9% | -12% | 14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,617.0 Cr | -2.1% | -9% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,655.0 Cr | 2.4% | 2.2% | 59.7% | Stock Analytics | |
CIPLA | ₹119,511.0 Cr | 1.4% | 2% | 0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,734.0 Cr | -0.9% | -2.8% | 16.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,705.1 Cr | -2.1% | -9.2% | -8.7% | Stock Analytics |
GRANULES INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GRANULES INDIA | 2.9% |
-12% |
14.5% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses